Mitchell Shirvan
13Patents
4h-index
28Co-inventors
60Inventor score
Filing activity: Jul 6, 1993 → Oct 20, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5585358A | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents | Chemistry; Metallurgy | 34 | Expired |
| US5914349A | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives | Chemistry; Metallurgy | 32 | Expired |
| US6528685B2 | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives | Chemistry; Metallurgy | 28 | Expired |
| US10398641B2 | Compositions and methods for treating rosacea and acne | Human Necessities | 14 | Active |
| US6555585B2 | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder | Human Necessities | 4 | Expired |
| US10849847B2 | Compositions and methods for treating rosacea and acne | Human Necessities | 2 | Active |
| US11324691B2 | Compositions and methods for treating rosacea and acne | Human Necessities | 1 | Active |
| US9168287B2 | Activated leukocyte conditioned supernatant and uses for wound healing | Human Necessities | 0 | Active |
| US10940241B2 | Formation of stable cartilage | Human Necessities | 0 | Active |
| US9439950B2 | Activated leukocyte conditioned supernatant and uses for wound healing | Human Necessities | 0 | Active |
| US8288442B2 | Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders | Human Necessities | 0 | Active |
| US9132154B2 | Activated leukocyte composition and uses for wound healing | Human Necessities | 0 | Active |
| US8574902B2 | Activated leukocyte composition and uses for wound healing | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.